Truvestments Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.2K Sell
328
-129
-28% -$9.66K ﹤0.01% 614
2025
Q4
$36.1K Hold
457
0.01% 500
2025
Q3
$37.6K Buy
457
+226
+98% +$17.8K 0.01% 481
2025
Q2
$18.6K Hold
231
﹤0.01% 547
2025
Q1
$18.6K Hold
231
﹤0.01% 565
2024
Q4
$18.9K Hold
231
﹤0.01% 506
2024
Q3
$19K Buy
+231
New +$17.3K 0.01% 497
2023
Q1
Sell
-69
Closed -$4.99K 852
2022
Q4
$4.99K Buy
+69
New +$4.94K ﹤0.01% 546
2021
Q2
Sell
-350
Closed -$21K 668
2021
Q1
$21K Hold
350
0.01% 367
2020
Q4
$16K Hold
350
0.01% 382
2020
Q3
$13K Sell
350
-217
-38% -$8.24K 0.01% 249
2020
Q2
$19K Buy
567
+190
+50% +$6.61K 0.02% 311
2020
Q1
$11K Buy
+377
New +$16.7K 0.01% 337
2019
Q4
Sell
-1,947
Closed -$92K 402
2019
Q3
$92K Sell
1,947
-472
-20% -$22.5K 0.06% 182
2019
Q2
$120K Sell
2,419
-2,400
-50% -$113K 0.08% 170
2019
Q1
$205K Buy
+4,819
New +$213K 0.16% 107
2018
Q3
$642K Sell
13,740
-593
-4% -$27.1K 0.31% 86
2018
Q2
$625K Buy
+14,333
New +$668K 0.39% 85

Other funds holding MET

Truvestments Capital's MET Position: Q1 2026 in Review

Truvestments Capital reduced its MetLife (MET) stake by 28% in Q1 2026, selling an estimated $9.66K and leaving 328 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

Truvestments Capital first reported a position in MET in Q2 2018 and has held it in 18 quarters since. The position peaked at $642K in Q3 2018. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Truvestments Capital held 328 shares of MetLife worth $23.2K as of Q1 2026.
  • Truvestments Capital sold 129 MetLife shares in Q1 2026, an estimated $9.66K.
  • MetLife made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #614 holding.
  • Truvestments Capital first reported a position in MetLife in Q2 2018 and has held it in 18 quarters since.
  • Truvestments Capital's MetLife position peaked at $642K in Q3 2018.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.